alexa
Reach Us +1 218 451 2974
Development of Novel HIV Vaccine by Nano-biomaterials | OMICS International | Abstract
ISSN: 2168-9652

Biochemistry & Physiology: Open Access
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Editorial

Development of Novel HIV Vaccine by Nano-biomaterials

Md Salahuddin1*, Md Sayfullah2, Mahjabin Rashid3, Jay Prakash Sah4, Md Abdul Momin5, Syfullah Shahriar6, Chandra Kant Yadav4, Bhupendra Sharma4, Mohammad Showkat Mahmud7 and Mohammad Alam Miah1
1Department of Physiology, Bangladesh Agricultural University, Mymensingh-2202, Bangladesh
2College of Medicine, Shaheed Ziaur Rahman Medical College Hospital, Bogra, University of Rajshahi, Bangladesh
3College of Medicine, Mymensingh Medical College and Hospital, University of Dhaka, Mymensingh, Bangladesh
4Department of Medical Laboratory Science, School of Health and Allied Sciences, Pokhara University, Lekhnath- 12, Kaski, Nepal
5Department of microbiology and hygiene, Bangladesh Agricultural University, Mymensingh-2202, Bangladesh
6Department of Soil Science, Sher-e-Bangla Agricultural University, Dhaka-1207, Bangladesh
7Bangladesh Livestock Research Institute, Animal Health Research Division, Savar, Dhaka- 1341, Bangladesh
Corresponding Author : Md Slaahuddin
Department of Physiology Bangladesh Agricultural University
Mymensingh-2202, Bangladesh
Tel: +8801745001875
E-mail: [email protected]
Received: May 14, 2015; Accepted: May 15, 2015; Published: May 22, 2015
Citation: Salahuddin M, Sayfullah M, Rashid M, Prakash Sah J, Abdul Momin M, et al. (2015) Development of Novel HIV Vaccine by Nano-biomaterials. Biochem Physiol 4:e136. doi:10.4172/2168-9652.1000e136
Copyright: © 2015 Salahuddin M, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

Human immune deficiency virus is a life threatening immune deficiency disease causing virus. Nowadays Nano-Medicine is a promising field for manufacturing vaccines for various bacterial and viral diseases. FPCN containing specific antigen are capable to stimulate T-cell very well to kill the viruses. P24 is the capsid protein of HIV virus which can stimulate immune response. So FPCN containing p24 will be a good choice for HIV vaccination. The present hypothesis aimed to quantify the challenges of making a novel HIV vaccine using FPCN nano-particles.

Keywords

Share This Page
add_chatinline();
Top